Response Genetics, Inc
RGDXQ · OTC
3/31/2015 | 12/31/2014 | 9/30/2014 | 6/30/2014 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -7.1% | -8.6% | 4.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 38.9% | 40.1% | 43.1% | 39.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -91% | -70.1% | -70.5% | -67.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -110.9% | -87.6% | -87.4% | -73.9% |
| EPS Diluted | -0.11 | -0.092 | -0.1 | -0.082 |
| % Growth | -19.3% | 7.8% | -22.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |